Cipla Ltd
Jan 18, 2012 at 08:15 | Source: CNBC-TV18
Jan 06, 2012 at 08:48 | Source: CNBC-TV18
Aug 04, 2011 at 20:30 | Source: PTI
Jun 30, 2011 at 16:17 | Source: PTI
Dec 09, 2010 at 17:07 | Source: Moneycontrol.com
Photos »
/ 
News across the web »
May 19, 2012 at 05:31 | Source: Economic Times
May 11, 2012 at 03:36 | Source: Business Standard
May 09, 2012 at 12:11 | Source: Economic Times
May 04, 2012 at 18:01 | Source: Wall Street Journal
May 04, 2012 at 12:01 | Source: Wall Street Journal
Interact & exchange stock tips & market info »
Related News »
BANGALORE— Cipla Ltd., one of India's largest generic drug manufacturers, said it is cutting prices on its cancer medicines by up to 75%, a move likely to further complicate efforts by big Western pharmaceutical companies seeking to develop ...
May 4, 2012 at 12:25 | Source: Wall Street Journal
Cipla Ltd reported a net profit of Rs 291.74 crore for the quarter ended March 31, 2012, compared to Rs 214 crore for the quarter ended March 31, 2011. According to an ET Now poll, the pharma major was expected to report a 34% YoY increase in its net ...
May 11, 2012 at 08:56 | Source: 4-traders (press release)
The Central Drugs Standard Control Organization which oversees clinical trials and India’s 10,000 drugmakers, approved medicines from companies including Novartis AG (NOVN), GlaxoSmithKline Plc (GSK) and Mumbai-based Cipla Ltd. (CIPLA ...
May 10, 2012 at 04:11 | Source: Businessweek
Swiss-based Roche Holding AG and local drug maker Cipla Ltd have decided to sharply cut prices for five of their high-cost oncology brands after the Indian patent office made its first compulsory licence order in March. Bayer didn’t say if it will lower ...
May 8, 2012 at 18:04 | Source: Livemint.com
The report also said that P. Prabhudesai, chest specialist at Lilavati Hospital in Mumbai, was one of the four doctors who approved Cipla Ltd’s drug pirfenidone, used to treat lung disorder, in 2010. Prabudesai denied ever having been in touch ...
May 11, 2012 at 16:20 | Source: Livemint.com
The BSE Auto Index lost 0.28%. The top gainers’ in the list comprised L&T, Cipla, Hero MotoCorp, ICICI Bank and DLF. NTPC, Maruti, Coal India Ltd, ONGC and Bharti Airtel remained the top losers. The overall breadth of the stock market was pessimistic on ...
May 15, 2012 at 07:19 | Source: Top News India
Apart from Mylan, Prinston Inc., Hetero Labs Ltd III, Strides, Cipla and Aurobindo Pharma have gained approval to market their generic versions of Viramune. According to IMS Health, Plavix generated U.S. revenues of approximately $6.7 billion for the 12 ...
May 24, 2012 at 21:41 | Source: NASDAQ
Apart from Mylan, Prinston Inc., Hetero Labs Ltd III, Strides, Cipla and Aurobindo Pharma have gained approval to market their generic versions of Viramune. According to IMS Health, Plavix generated U.S. revenues of approximately $6.7 billion ...
May 24, 2012 at 21:05 | Source: Yahoo Finance
Among the stocks leading the gains are Cipla and L&T. Indian stock markets have reversed ... Mining stocks have been trading mixed with Gujarat NRE Coke and Sesa Goa Ltd. leading the gainers and Ashapura Minechem Ltd. and NMDC Ltd. trading the weakest.
May 15, 2012 at 16:58 | Source: MSN India
Pearl Polymers Ltd (PPL) is focused on manufacturing of polyethylene terephthalate ... Some of the company's clients include Cipla, Novartis, Cadbury's, Marico, Tata Tea, Paras, Hindustan Unilever Limited, McDowell and Himalayas. PPL markets its products ...
May 19, 2012 at 22:37 | Source: Transworld News